United States Antimony Co. (NYSEAMERICAN:UAMY) Given Consensus Recommendation of "Buy" by Brokerages

Key Points

• All five covering brokerages rate UAMY a "Buy" with a consensus 12‑month price target of $8.75, and recent analyst targets raised up to $11.00 (B. Riley) and $10.25 (HC Wainwright).
• Shares trade near $9.22 with 50‑day/200‑day SMAs of $8.63/$7.62, a market cap of about $1.29 billion and a negative PE (‑922), indicating volatile/unprofitable earnings.
• Institutional ownership is low (~9.49%), though several hedge funds and small managers have recently initiated or increased positions.

Shares of United States Antimony Co. (NYSEAMERICAN:UAMY - Get Free Report) have received a consensus recommendation of "Buy" from the five brokerages that are currently covering the company, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $8.75.

Several research firms recently weighed in on UAMY. HC Wainwright restated a "buy" rating and set a $10.25 price target on shares of United States Antimony in a report on Tuesday, February 3rd. B. Riley Financial increased their price objective on shares of United States Antimony from $9.00 to $11.00 and gave the company a "buy" rating in a research note on Tuesday, February 24th. Finally, Alliance Global Partners restated a "buy" rating on shares of United States Antimony in a research note on Wednesday, February 11th.

Institutional Trading of United States Antimony

A number of hedge funds have recently bought and sold shares of the business. CoreCap Advisors LLC bought a new position in United States Antimony in the 4th quarter valued at $27,000. Nova Wealth Management Inc. increased its position in shares of United States Antimony by 405.0% during the 3rd quarter. Nova Wealth Management Inc. now owns 5,050 shares of the company's stock valued at $31,000 after purchasing an additional 4,050 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of United States Antimony during the 2nd quarter worth $33,000. Meeder Asset Management Inc. purchased a new position in shares of United States Antimony in the 4th quarter worth about $35,000. Finally, Harbour Investments Inc. boosted its holdings in shares of United States Antimony by 106.2% in the 4th quarter. Harbour Investments Inc. now owns 7,962 shares of the company's stock worth $40,000 after buying an additional 4,101 shares during the last quarter. 9.49% of the stock is currently owned by institutional investors.

United States Antimony Trading Down 4.8%

Shares of NYSEAMERICAN:UAMY opened at $9.22 on Friday. The stock's fifty day simple moving average is $8.63 and its two-hundred day simple moving average is $7.62. United States Antimony has a 1-year low of $1.57 and a 1-year high of $19.71. The stock has a market cap of $1.29 billion, a PE ratio of -922.00 and a beta of -0.01.

About United States Antimony

United States Antimony Corporation is a specialized mining and chemical company focused primarily on the production and processing of antimony and antimony-based compounds. The company operates its own extraction and milling facilities to recover antimony metal and antimony trioxide, which serve as critical raw materials in industries such as flame retardants for plastics and textiles, catalysts for chemical processes, and additives for glass and ceramics. In addition to antimony, United States Antimony maintains smaller-scale gold and silver operations in Mexico that provide supplementary revenue streams and diversification of its mineral portfolio.

Founded in the mid-20th century, United States Antimony has evolved from a single‐mine operator into a multinational enterprise with mining and processing sites in both the United States and Mexico.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.